摘要
IgA肾病(IgAN)是最常见的慢性肾小球肾炎之一,但明确的病因和发病机制仍不清楚。该疾病与多种潜在机制有关,其中黏膜免疫反应是重要的致病因素之一。而微生物产生的IgA蛋白酶和细胞因子都会在免疫作用中引起相应的组织学改变。目前,微生物的多样性分析与IgAN患者的临床疗效和预后有紧密的联系。随着致病机制相关研究的开展,许多IgAN的临床治疗数据也逐渐被发现。因此,探讨IgAN与微生物相关的免疫机制对IgAN的有效治疗具有重要意义。
IgA nephropathy(IgAN)is one of the most common types of chronic glomerulonephritis,but the definite etiology and pathogenesis of IgAN are still unclear.IgAN is related to a variety of potential mechanisms,among which mucosal immune response is one of the important pathogenic factors.However,IgA protease and cytokines produced by microorganisms can cause corresponding histological changes via immune pathways.At present,the microbial diversity is considered to be closely related to the efficacy of clinical treatment and prognosis of IgAN.With the increasing researches on related pathogenic mechanisms,the clinical data of IgAN treatment have been on the rise as well.Therefore,exploring the microbe-related immune mechanisms in IgAN is of great significance for the effective treatment of IgAN.
作者
朱安超
杨鑫鑫
候云晶
孟宏学
An-chao Zhu;Xin-xin Yang;Yun-jing Hou;Hong-xue Meng(Department of Pathology,Harbin Medical University Cancer Hospital,Harbin,Heilongjiang 150081,China)
出处
《中国现代医学杂志》
CAS
北大核心
2021年第2期33-37,共5页
China Journal of Modern Medicine
基金
国家自然科学基金(No:81600539)
哈尔滨医科大学附属肿瘤医院杰出青年项目(No:JCQN2018-05)。